Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
As I recall hasn't an insurer already been implicated in infringement?
This could expand to retailers as well.
Nice read. Thank you.
I might add to your comments about jurors not understanding the complexities of the concepts that are involved.
The same may be said about the judges and other legal participants in this case. Du for example.
IMO
Yes, this has all been a monumental disaster that has been discussed many times since the infamous decision.
Of course, it all began with the selection of the wrong venue to hear the case and went downhill from there.
That a single person with no knowledge of the subject matter can make a pivotal decision which supersedes the patent office is ludicrous.
Two lost appeals is even more so.
But that is where we are in an environment in which vultures are allowed to capitalize on others' work.
In the end we are all talking to ourselves.
IMO
If IFUS reports sales ramp up the pps will /should begin to lead the sales reports as the price anticipates further sales gains.
This would not be an unusual circumstance.
At that point the discussions about IFUS legitimacy will be moot.
We'll all see soon enough.
IMO
Jasbg,
Same here, we aren't starving, yet. LOL
As you said some things happen with age and are expected. So we live with them.
Your camper looks very nice. Enjoy your summer adventures. Best to you and your spouse.
GLTU and GLTA here.
Sorry to hear your saga.
I'm sure many here have similar stories, myself included.
Hopefully we live long enough to see Amarin turn around.
Meanwhile, it's as you said, get up every morning to check Amarin pps and ihub board.
GLTU
Many hope you are correct.
I do.
Thank you for your courteous reply regarding your investment and opinions on Amarin.
Like you, I was here before R-IT and in spite of all that has occurred remained optimistic for quite a while.
I sold some of my shares a while ago and invested in NVO which has performed well since the purchase but still hold a position in AMRN hoping that
it recovers as you suggest.
Recovery is relative of course based on entry point. The other relevant issue is the remaining runway for each of us which is obviously person specific.
GLTU/GLTA
Like you, I bought and held Amarin through the post Reduce It run up and then the decline after the Du decision.
All along the hope was that Amarin would prevail after the post Du decision.
And like you I've been retired for 3 years now with the hope that Amarin would recover. I retired very late and am now 75 years old. It looks like
if Amarin ever recovers only my estate will benefit.
Many of us, myself include, wish we would have taken our gains when the stock hit the 20's but were fooled into believing it was just the beginning of things for Amarin.
So every day I look for news that would provide a catalyst for recovery.....Brave, EU, China, etc. Frankly I'm not sure there are any potential buyers of Amarin and any successes in moving the pps will only be a result of their own actions. And that will take some time if ever. I know this is not a popular conclusion but look where we all are. Not a negative opinion just a statement of reality. We are under $1, again.
IFUS is the only one I'm in.
It's gone up a lot from getting in.
We'll see where it goes from here.
Thanks for your response.
The one I referred to from yesterday showed confirmed.
So I got fooled.
Thanks again.
Interesting as other sources said .56 for February 2024 just yesterday.
Looks like your number is the correct one.
Thanks
l wish the best to you going forward.
Sorry to hear of your misfortunes.
Stay close to your son as you are now both parents to him.
I say these words with the similar life experiences of my own.
Best fortunes in 2024 and beyond. AMRN is not the most important issue in life as it turns out.
Is oil absorption still in the plan/works?
I agree that if results were out positive or negative we may have seen commentary or affect on pps.
Guess we will have to wait it out unless someone can find definitive results.
I have continued to search for the results of this trial but have found nothing.
I will continue as I can.
It is curious that the trial description describes that high doses of fish oil will be administered.
Vascepa has still not been differentiated from fish oil apparently. Even in the medical community.
Let's all just wait and see.
That is the point of disagreement.
Some think the results were presented as per the conclusion statement of Lp 019.
Some think that results were not reported.
Reasoning from what is written indicates they were presented and were not favorable since pps remains low.
But right now no concrete proof exists either way.
Sleven has appealed for clarification and we all await a response.....hopefully.
I found the line you quoted which led me to believe that results were reported.
But I couldn't find the pdf that is suppose to be available.
Hopefully Sleven's inquiry will resolve this.
Sleven,
Thank you for your reply.
I came to the same conclusion regarding the results not meeting end points. Unfortunately.
I assume we may have seen the pps move up more had results been stellar.
Thank you for the information.
Looks like the BRAVE results have been presented.
I found the abstract for LP 019 which stated the results would be presented at the conference.
Did not, however find the results. Perhaps I missed something that would lead me there.
If this is a viable action would /should Amarin be aware of it on their own volition?
I assume astute counsel would suggest such action unless they have already considered it and dismissed it.
Just got my SS statement for 2024.
Part B is $174 and change.
Hopefully we will also see sales in the US.
That should be more immediate than the evolution of a partnership in India. IMO
It will be interesting to following the joint venture development as it relates to all the business and legal issues that are involved in such a deal.
Lots of things to think about to protect all of IFUS' interests.
Seems like the FDA would/should also be concerned about all of this.
Just IMO from a "lurking" board follower.
Thank you for your response.
One would assume that the bagasse conversion would take place shortly after receipt.
I'd like to see pictures of the converted bagasse being shipped out.
And then we could expect a report of sales.
Twelve truck loads of what?
It looks like it is arriving at the plant.
Is this bagasse?
Thanks
Very nice presentation.
Hoping we will see/hear a response.
DAR53,
Thank you for your reply.
Like you I am hoping for a catalyst that will positively affect the share price. And hopefully one that has a longer lasting effect.
Many here are significantly under water (myself included) and hope to get to a point that we can feel comfortable getting out.
For me break even would look ok.
GLTA as you said.
Waiting to get out of this investment nightmare just like many others. Not "lurking" at all.
I just don't post incessantly.
Regarding what Sarissa is doing my opinions are just as valid as others since none of us knows whats going on for sure.
Except what is right in front of our eyes. SP below $1.00.
Seems like the topic of reverse split was been brought up before my post.
IMO
My posts are infrequent due to the adolescent, obtuse, and sarcastic responses.
Such as yours.
It's a safe bet that Sarissa will try to recapture its $100M and make a profit on it.
But their method may be entirely different than what was originally thought and most likely won't be good for the rest of us.
Beyond that, I wrote this morning to both Amarin and Sarissa about their lack of communication. And how they are no better than the previous Amarin management.
Of course, no response.
We are a couple days into sub $1.00 closing. Are we on our way to a reverse split to correct this?
Your post summarizes nicely the SGP+ attributes.
Earlier in 2023 the expectation was that sales and profits would rise in 2023.
Now we are looking at the next 12 months which puts us out well into 2024.
The rolling horizon becomes problematic after successive extensions.
Hopefully the company will provide numbers this year that support a ramping growth trend.
IFUS stock is still in the traders hands.
Sales and profits shocking to the up side will be needed to move the stock out of traders' hands.
IMO
I assume that you mean 2023 by "this year".
That only leaves 3 1/2 months or so for us to see something significant.
Significant being an undefined term.
In my mind going to .05 could be deemed significant from a percentage standpoint.
But unless I'm missing something that's not the pps we are looking for.
Guess we'll see.
Thanks for your response.
I was just comparing numbers that were reported by others.
Not sure of the units involved.
And if the numbers are true the volume is 50% of the US already.
Does that seem possible?
Or am I making an error?
I don't visit this board very often any more but when I do the complexion of the board hasn't changed.
But the company seems to have changed for the worse.
It seems they have gone dark.
Not much to look forward to here no matter what anyone says.
Thank you for your response.
I have been watching and will continue.
This article and the one that was previously posted regarding herd management are interesting.
But nowhere in either article was there a mention of SGP+ as a potential solution to the issues.
It seems that the industry is not aware of SGP+. How is that being bridged?
Lack of knowledge of SGP+ and what it may offer is problematic in ramping sales.
IMO